Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection

Published:2022-10-01 Issue:10 Volume:45 Page:1559-1563
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Hayashi Yasuhiro¹,Matsuda Kouki²,Tanigawa Kazunari³,Tanikawa Takashi⁴,Maeda Kenji⁵,Tsuchiya Kiyoto⁶

Affiliation:

1. Faculty of Agriculture, University of Miyazaki

2. Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute

3. Faculty of Pharma-Sciences, Teikyo University

4. Faculty of Pharmacy and Pharmaceutical Sciences, Josai University

5. Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University

6. AIDS Clinical Center, National Center for Global Health and Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/10/45_b22-00503/_pdf

Reference21 articles.

1. 1) Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A Novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med., 382, 727–733 (2020).

2. 2) Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270–273 (2020).

3. 3) Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med., 382, 1199–1207 (2020).

4. 4) Mitsuya H, Kokudo N. Sustaining containment of COVID-19: Global sharing for pandemic response. Glob. Health Med, 2, 53–55 (2020).

5. 5) Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19—Final report. N. Engl. J. Med., 383, 1813–1826 (2020).